Clinical test results affect several stocks


Clinical Trial Results Affect Several Stocks
When disappointing clinical trial news sent Affymax shares plunging 69% last Monday — the greatest one-day Nasdaq drop ever — the ripple effect was more subtle.

Read more on Investor’s Business Daily via Yahoo! News

Leave a Reply